Draft federal clinical practice guidelines for the diagnosis, treatment, and prevention of vitamin D deficiency

This draft clinical practice guideline for the diagnosis, treatment and prevention of vitamin D deficiency is an update from a previous 2016 document. An analysis of the relevant literature data was carried out, with particular attention to meta-­analyzes, randomized clinical trials and systematic reviews published over the past 5 years. The updated recommendations were discussed and revised by the leading endocrinologists of the Russian Federation, who have expert status in this issue.

The classification of 25(OH)D levels has been revised (in particular, the target range of 25(OH)D values has been specified), recommendations have been developed for screening of the disorders associated with vitamin D deficiency. The concept of vitamin D-associated toxicity and recommendations for its diagnosis and prevention have been introduced. Also, indications for the assessment of other vitamin D metabolites besides 25(OH)D, the main marker of vitamin D status, have been indicated.

The section regarding treatment of vitamin D deficiency has been expanded and corrected. The major additions concerned the replenishment of the vitamin D deficiency and insufficiency in certain categories of patients (particularly, in the presence of the chronic kidney disease and autoimmune diseases, as well as in pregnant women) and monitoring of the effectiveness and safety of the therapy. The indications for prescribing active metabolites of vitamin D have been adjusted. Recommendations for the prevention of vitamin D deficiency in the general population have also been revised, taking into account large randomized clinical trials, meta-analyzes and systematic reviews of recent years.

This publication is an expanded version of the federal guidelines.

1. Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319-329. doi: https://doi.org/10.1016/j.chembiol.2013.12.016

2. Cameron ID, Dyer SM, Panagoda CE, et al. Dietary Reference Intakes for Calcium and Vitamin D. Washington, D.C.: National Academies Press; 2011. doi: https://doi.org/10.17226/13050

3. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930. doi: https://doi.org/10.1210/jc.2011-0385

4. Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Holick MF. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab. 1987;64(6):1165-1168. doi: https://doi.org/10.1210/jcem-64-6-1165

5. Wacker M, Holick MF. Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinology. 2013;5(1):51-108. doi: https://doi.org/10.4161/derm.24476

6. Clemens TL, Henderson SL, Adams JS, Holick MF. Increased Skin Pigment Reduces the Capacity of Skin To Synthesise Vitamin D3. Lancet. 1982;319(8263):74-76. doi: https://doi.org/10.1016/S0140-6736(82)90214-8

7. Hong J, Hatchell KE, Bradfield JP, et al. Transethnic Evaluation Identifies Low-Frequency Loci Associated with 25-Hydroxyvitamin D Concentrations. J Clin Endocrinol Metab. 2018;103(4):1380-1392. doi: https://doi.org/10.1210/jc.2017-01802

8. Mao S, Huang S. Vitamin D receptor gene polymorphisms and the risk of rickets among Asians: A meta-analysis. Arch Dis Child. 2014;99(3):232-238. doi: https://doi.org/10.1136/archdischild-2013-304379

9. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988;67(2):373-378. doi: https://doi.org/10.1210/jcem-67-2-373

10. Chen TC, Chimeh F, Lu Z, et al. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys. 2007;460(2):213-217. doi: https://doi.org/10.1016/j.abb.2006.12.017

11. Pereira-Santos M, Costa PRF, Assis AMO, et al. Obesity and vitamin D deficiency: A systematic review and meta-analysis. Obes Rev. 2015;16(4):341-349. doi: https://doi.org/10.1111/obr.12239

12. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690-693. doi: https://doi.org/10.1093/ajcn/72.3.690

13. Yang L, Weaver V, Smith JP, Bingaman S, Hartman TJ, Cantorna MT. Therapeutic effect of vitamin D supplementation in a pilot study of Crohn’s patients. Clin Transl Gastroenterol. 2013;4(4):e33. doi: https://doi.org/10.1038/ctg.2013.1

14. Nuti R, Martini G, Valenti R, et al. Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern Med. 2001;250(4):361-366. doi: https://doi.org/10.1046/j.1365-2796.2001.00895.x

15. Gilman J, Shanahan F, Cashman KD. Determinants of vitamin D status in adult Crohn’s disease patients, with particular emphasis on supplemental vitamin D use. Eur J Clin Nutr. 2006;60(7):889-896. doi: https://doi.org/10.1038/sj.ejcn.1602395

16. Chakhtoura M, Nakhoul N, Shawwab K, et al. Hypovitaminosis D in Bariatric Surgery: A Systematic Review of Observational Studies. Metabolism. 2016;65(4):574-585. doi: https://doi.org/10.1016/j.metabol.2015.12.004

17. Aasheim ET, Björkman S, Søvik TT. Vitamin status after bariatric surgery: A randomized study of gastric bypass and duodenal switch (American Journal of Clinical Nutrition (2009) 90, (15-22)). Am J Clin Nutr. 2010;91(1):15-22. doi: https://doi.org/10.3945/ajcn.2009.28846

18. Schmidt-Gayk H, Grawunder C, Tschöpe W, et al. 25-Hydroxy-Vitamin-D in Nephrotic Syndrome. Lancet. 1977;310(8029):105-108. doi: https://doi.org/10.1016/S0140-6736(77)90118-0

19. Stokes CS, Volmer DA, Grünhage F, Lammert F. Vitamin D in chronic liver disease. Liver Int. 2013;33(3):338-352. doi: https://doi.org/10.1111/liv.12106

20. Karakelides H, Geller JL, Schroeter AL, et al. Vitamin D-mediated hypercalcemia in slack skin disease: Evidence for involvement of extrarenal 25-hydroxyvitamin D 1α-hydroxylase. J Bone Miner Res. 2006;21(9):1496-1499. doi: https://doi.org/10.1359/jbmr.060608

21. Grey A, Lucas J, Horne A, Gamble G, Davidson JS, Reid IR. Vitamin D Repletion in Patients with Primary Hyperparathyroidism and Coexistent Vitamin D Insufficiency. JCEM. 2015;90:2122-2126. doi: https://doi.org/10.1210/jc.2004-1772

22. Robien K, Oppeneer SJ, Kelly JA, Hamilton-Reeves JM. Drug-Vitamin D Interactions: A Systematic Review of the Literature. Nutr Clin Pract. 2013;28(2):194-208. doi: https://doi.org/10.1177/0884533612467824

23. Binkley N, Dawson-Hughes B, Durazo-Arvizu R, et al. Vitamin D Measurement Standardization: The Way Out of the Chaos. J Steroid Biochem Mol Biol. 2016;(12):S0960-0760. doi: https://doi.org/10.1016/j.jsbmb.2016.12.002

24. Looker AC, Pfeiffer CM, Lacher DA, et al. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 versus 2000-2004. Am J Clin Nutr. 2009;88(6):1519-1527. doi: https://doi.org/10.3945/ajcn.2008.26182

25. Cashman KD, Dowling KG, Škrabáková Z, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016;103(4):1033-1044. doi: https://doi.org/10.3945/ajcn.115.120873

26. Karonova TL, Grinyova EN, NikitiM IL, et al. The prevalence of vitamin d deficiency in the northwestern region of the Russian Federation among the residents of St. Petersburg and Petrozavodsk. Osteoporosis and Bone Diseases. 2013;16(3):3-7. (In Russ.). doi: https://doi.org/10.14341/osteo201333-7

27. Markova TN, Markov DS, Markelova TN, et al. Rasprostranennost’ defitsita vitamina D i faktorov riska osteoporoza u lits molodogo vozrasta. Vestnik Chuvashskogo Universiteta. 2012;234(3):441-446. (In Russ.).

28. Agureeva OV, Zhabreva TO, Skvortsova EA, et al. Analiz urovnya vitamina D v syvorotke krovi patsientov v Rostovskoy oblasti. Osteoporosis and Bone Diseases. 2016;19(2):47-47. (In Russ.) doi: https://doi.org/10.14341/osteo2016247-47

29. Romantsova EP, Borisenko EB, Babtseva AF. Vitamin D provision for children and adult population of the Amur region. Bull Physiol Pathol Respir. 2016;60:57-61. (In Russ.). doi: https://doi.org/10.12737/20121

30. Malyavskaya SI, Kostrova GN, Lebedev АV, et al. 25(OH)D Levels in the population of Arkhangelsk city in different age groups. Hum Ecol. 2018;25(1):60-64. (In Russ.). doi: https://doi.org/10.33396/1728-0869-2018-1-60-64

31. Nurlygayanov R.Z., Syrtlanova E.R., Minasov T.B., Borisov I.V. The level of vitamin D in people over than 50 years old residing in the republic of Bashkortostan in the period of maximum insolation. Osteoporosis and Bone Diseases. 2015;18(1):7-9. (In Russ.). doi: https://doi.org/10.14341/osteo201517-9

32. Nurlygayanov R.Z., Syrtlanova E.R. Prevalence of vitamin D deficiency in people over 50 years old residing in republic of Bashkortostan in periods of low insolation. Osteoporosis and Bone Diseases. 2012;15(3):7-9. (In Russ.). doi: https://doi.org/10.14341/osteo201237-9

33. Spasich T.A., Lemeshevskaya E.P., Reshetnik L.A., i dr. Gigienicheskoe znachenie defitsita vitamina D u naseleniya Irkutskoi oblasti i puti ego profilaktiki. Byulleten’ VSNTs SO RAMN. 2014;6(100):44-47. (In Russ.).

34. Khazova EL, Shirinyan LV, Zazerskaya IE, et al. Season fluctuations of level of 25-hydroxycholecalciferol in pregnant women living in Saint Petersburg. Gynecology. 2015;17(4):38-42. (In Russ.).

35. Suplotova LA, Avdeeva VA, Pigarova EA, et al. The first Russian multicenter non-interventional registry study to study the incidence of vitamin D deficiency and insufficiency in Russian Federation. Ter Arkh. 2021;93(10):1209-1216. (In Russ.). doi: https://doi.org/10.26442/00403660.2021.10.201071

36. Avdeeva VA, Suplotova LA, Pigarova EA, et al. Vitamin D deficiency in Russia: the first results of a registered, non-interventional study of the frequency of vitamin D deficiency and insufficiency in various geographic regions of the country. Problems of Endocrinology. 2021;67(2):84-92. (In Russ.). doi: https://doi.org/10.14341/probl12736

37. Pigarova EA, Rozhinskaya LY, Katamadze NN, et al. Prevalence of vitamin D deficiency in various regions of the Russian Federation: results of the first stage of the multicenter cross-sectional randomized study. Osteoporosis and Bone Diseases. 2021;23(4):4-12. (In Russ.). doi: https://doi.org/10.14341/osteo12701

38. Hollis BW, Wagner CL. Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant. Am J Clin Nutr. 2004;80(S6):1752-1758. doi: https://doi.org/10.1093/ajcn/80.6.1752s

39. Lee JM, Smith JR, Philipp BL, et al. Vitamin D deficiency in a healthy group of mothers and newborn infants. Clin Pediatr (Phila). 2007;46(1):42-44. doi: https://doi.org/10.1177/0009922806289311

40. Bodnar LM, Simhan HN, Powers RW, et al. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr. 2007;137(2):447-452. doi: https://doi.org/10.1093/jn/137.2.447

41. Heaney RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr. 2004;80(S6):1706-1709. doi: https://doi.org/10.1093/ajcn/80.6.1706s

42. Holick MF, Siris ES, Binkley N, et al. Prevalence of Vitamin D Inadequacy among Postmenopausal North American Women Receiving Osteoporosis Therapy. J Clin Endocrinol Metab. 2005;90(6):3215-3224. doi: https://doi.org/10.1210/jc.2004-2364

43. Minisola S, Colangelo L, Pepe J, et al. Osteomalacia and Vitamin D Status: A Clinical Update 2020. JBMR Plus. 2021;5(1). doi: https://doi.org/10.1002/jbm4.10447

44. Plotnikoff GA, Quigley JM. Prevalence of Severe Hypovitaminosis D in Patients with Persistent, Nonspecific Musculoskeletal Pain. Mayo Clin Proc. 2003;78(12):1463-1470. doi: https://doi.org/10.4065/78.12.1463

45. Malabanan AO, Turner AK, Holick MF. Severe generalized bone pain and osteoporosis in a premenopausal black female: Effect of vitamin D replacement. J Clin Densitom. 1998;1(2):201-204. doi: https://doi.org/10.1385/JCD:1:2:201

46. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture Prevention With Vitamin D Supplementation. JAMA. 2005;293(18):2257-2264. doi: https://doi.org/10.1001/jama.293.18.2257

47. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials. BMJ. 2009;339(7725):843. doi: https://doi.org/10.1136/bmj.b3692

48. Krist AH, Davidson KW, Mangione CM, et al. Screening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(14):1436-1442. doi: https://doi.org/10.1001/jama.2021.3069

49. Cesareo R, Attanasio R, Caputo M, et al. Italian association of clinical endocrinologists (AME) and Italian chapter of the American association of clinical endocrinologists (AACE) position statement: Clinical management of vitamin D deficiency in adults. Nutrients. 2018;10(5):1-22. doi: https://doi.org/10.3390/nu10050546

50. Giustina A, Adler RA, Binkley N, et al. Consensus statement from 2nd International Conference on Controversies in Vitamin D. Rev Endocr Metab Disord. 2020;21(1):89-116. doi: https://doi.org/10.1007/s11154-019-09532-w

51. Giustina A, Bouillon R, Binkley N, et al. Controversies in Vitamin D: A Statement From the Third International Conference. JBMR Plus. 2020;4(12):1-13. doi: https://doi.org/10.1002/jbm4.10417

52. Máčová L, Bičíková M. Vitamin D: Current challenges between the laboratory and clinical practice. Nutrients. 2021;13(6). doi: https://doi.org/10.3390/nu13061758

53. Miller WG, Myers GL, Gantzer M Lou, et al. Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem. 2011;57(8):1108-1117. doi: https://doi.org/10.1373/clinchem.2011.164012

54. Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions. Endocr Rev. 2019;40(4):1109-1151. doi: https://doi.org/10.1210/er.2018-00126

55. Sempos CT, Vesper HW, Phinney KW, et al. Vitamin D status as an international issue: National surveys and the problem of standardization. Scand J Clin Lab Invest. 2012;72(S.243):32-40. doi: https://doi.org/10.3109/00365513.2012.681935

56. Carter GD, Jones JC, Shannon J, et al. 25-Hydroxyvitamin D assays: Potential interference from other circulating vitamin D metabolites. J Steroid Biochem Mol Biol. 2016;164:134-138. doi: https://doi.org/10.1016/j.jsbmb.2015.12.018

57. Aspray TJ, Bowring C, Fraser W, et al. National osteoporosis society vitamin D Guideline Summary. Age Ageing. 2014;43(5):592-595. doi: https://doi.org/10.1093/ageing/afu093

58. Rizzoli R, Boonen S, Brandi M-L, et al. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin. 2013;29(4):305-313. doi: https://doi.org/10.1185/03007995.2013.766162

59. Sai AJ, Walters RW, Fang X, Gallagher JC. Relationship between Vitamin D, Parathyroid Hormone, and Bone Health. J Clin Endocrinol Metab. 2011;96(3):E436-E446. doi: https://doi.org/10.1210/jc.2010-1886

60. Heaney RP, Dowell MS, Hale C a, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr. 2003;22(2):142-146. doi: https://doi.org/10.1080/07315724.2003.10719287

61. Barger-Lux MJ, Heaney RP. Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab. 2002;87(11):4952-4956. doi: https://doi.org/10.1210/jc.2002-020636

62. Priemel M, von Domarus C, Klatte TO, et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res. 2010;25(2):305-312. doi: https://doi.org/10.1016/S0084-3873(10)79798-4

63. Boonen S, Vanderschueren D, Haentjens P, Lips P. Calcium and vitamin D in the prevention and treatment of osteoporosis — A clinical update. J Intern Med. 2006;259(6):539-552. doi: https://doi.org/10.1111/j.1365-2796.2006.01655.x

64. Boonen S, Lips P, Bouillon R, et al. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: Evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab. 2007;92(4):1415-1423. doi: https://doi.org/10.1210/jc.2006-1404

65. Bouillon R, Van Schoor NM, Gielen E, et al. Optimal vitamin D status: A critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab. 2013;98(8):E1283-E1304. doi: https://doi.org/10.1210/jc.2013-1195

66. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003;326(7387):469. doi: https://doi.org/10.1136/bmj.326.7387.469

67. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency. Arch Intern Med. 2009;169(6):551. doi: https://doi.org/10.1001/archinternmed.2008.600

68. Pittas AG, Dawson-Hughes B, Sheehan P, et al. Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med. 2019;381(6):520-530. doi: https://doi.org/10.1056/nejmoa1900906

69. Manson JE, Bassuk SS, Buring JE. Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials. J Steroid Biochem Mol Biol. 2020;198:105522. doi: https://doi.org/10.1016/j.jsbmb.2019.105522

70. Scragg R. The Vitamin D Assessment (ViDA) study – Design and main findings. J Steroid Biochem Mol Biol. 2020;198:105562. doi: https://doi.org/10.1016/j.jsbmb.2019.105562

71. Luxwolda MF, Kuipers RS, Kema IP, et al. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115nmol/l. Br J Nutr. 2012;108(9):1557-1561. doi: https://doi.org/10.1017/S0007114511007161

72. Khan NB, Nawaz MA, Ijaz A, et al. Biochemical spectrum of parathyroid disorders diagnosed at a tertiary care setting. J Pak Med Assoc. 2020;70(2):243-247. doi: https://doi.org/10.5455/JPMA.302643153

73. Salman-Monte TC, Torrente-Segarra V, Vega-Vidal AL, et al. Bone mineral density and vitamin D status in systemic lupus erythematosus (SLE): A systematic review. Autoimmun Rev. 2017;16(11):1155-1159. doi: https://doi.org/10.1016/j.autrev.2017.09.011

74. Davidson ZE, Walker KZ, Truby H. Do glucocorticosteroids alter vitamin D status? A systematic review with meta-analyses of observational studies. J Clin Endocrinol Metab. 2014;97(3):738-744. doi: https://doi.org/10.1210/jc.2011-2757

75. Kieboom BCT, Kiefte-De Jong JC, Eijgelsheim M, et al. Proton Pump Inhibitors and Hypomagnesemia in the General Population: A Population-Based Cohort Study. Am J Kidney Dis. 2015;66(5):775-782. doi: https://doi.org/10.1053/j.ajkd.2015.05.012

76. Deng X, Song Y, Manson JAE, et al. Magnesium, vitamin D status and mortality: Results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III. BMC Med. 2013;11(1):1. doi: https://doi.org/10.1186/1741-7015-11-187

77. Rude RK, Adams JS, Ryzen E, et al. Low Serum Concentrations of 1,25-Dihydroxyvitamin D in Human Magnesium Deficiency. J Clin Endocrinol Metab. 1985;61(5):933-940. doi: https://doi.org/10.1210/jcem-61-5-933

78. Reddy V, Sivakumar B. Magnesium-dependent vitamin-D-resistant rickets. Lancet. 1974;303(7864):963-965. doi: https://doi.org/10.1016/S0140-6736(74)91265-3

79. Allgrove J, Adami S, Fraher L, et al. Hypomagnesaemia: Studies of Parathyroid Hormone Secretion and Function. Clin Endocrinol (Oxf). 1984;21(4):435-449. doi: https://doi.org/10.1111/j.1365-2265.1984.tb03230.x

80. Thode J, Juul-Jørgensen B, Bhatia HM, et al. Comparison of serum total calcium, albumin-corrected total calcium, and ionized calcium in 1213 patients with suspected calcium disorders. Scand J Clin Lab Investig. 1989;49(3):217-223. doi: https://doi.org/10.1080/00365518909089086

81. Liberman UA. Vitamin D-resistant diseases. J Bone Miner Res. 2007;22(S.2):105-107. doi: https://doi.org/10.1359/jbmr.07s210

82. Bergwitz C, Jüppner H. Disorders of phosphate homeostasis and tissue mineralisation. In: Calcium and Bone Disorders in Children and Adolescents; 2009. 300 p.

83. Azer SM, Vaughan LE, Tebben PJ, Sas DJ. 24-Hydroxylase Deficiency Due to CYP24A1 Sequence Variants: Comparison With Other Vitamin D−mediated Hypercalcemia Disorders . J Endocr Soc. 2021;5(9):1-10. doi: https://doi.org/10.1210/jendso/bvab119

84. Schlingmann KP, Kaufmann M, Weber S, et al. Mutations in CYP24A1 and Idiopathic Infantile Hypercalcemia. N Engl J Med. 2011;365(5):410-421. doi: https://doi.org/10.1056/NEJMoa1103864

85. Kaufmann M, Gallagher JC, Peacock M, et al. Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD. J Clin Endocrinol Metab. 2014;99(7):2567-2574. doi: https://doi.org/10.1210/jc.2013-4388

86. Kaufmann M, Morse N, Molloy BJ, et al. Improved Screening Test for Idiopathic Infantile Hypercalcemia Confirms Residual Levels of Serum 24,25-(OH)2D3 in Affected Patients. J Bone Miner Res. 2017;32(7):1589-1596. doi: https://doi.org/10.1002/jbmr.3135

87. Kaufmann M, Schlingmann KP, Berezin L, et al. Differential diagnosis of vitamin D–related hypercalcemia using serum vitamin D metabolite profiling. J Bone Miner Res. 2021;36(7):1340-1350. doi: https://doi.org/10.1002/jbmr.4306

88. Ginsberg C, Hoofnagle AN, Katz R, et al. The Vitamin D Metabolite Ratio Is Associated With Changes in Bone Density and Fracture Risk in Older Adults. J Bone Miner Res. 2021;36(12):2343-2350. doi: https://doi.org/10.1002/jbmr.4426

89. Ginsberg C, Katz R, de Boer IH, et al. The 24,25 to 25-hydroxyvitamin D ratio and fracture risk in older adults: The cardiovascular health study. Bone. 2018;107:124-130. doi: https://doi.org/10.1016/j.bone.2017.11.011

90. Bhadada SK, Padala RK, Bhansali A, et al. Visual vignette. Endocr Pract. 2009;15(7):767. doi: https://doi.org/10.4158/EP09157.VVR

91. Bereket A, Casur Y, Firat P, Yordam N. Brown tumour as a complication of secondary hyperparathyroidism in severe long-lasting vitamin D deficiency rickets. Eur J Pediatr. 2000;159(1-2):70-73. doi: https://doi.org/10.1007/PL00013807

92. Parfitt AM, Rao DS, Stanciu J, et al. Irreversible bone loss in osteomalacia. Comparison of radial photon absorptiometry with iliac bone histomorphometry during treatment. J Clin Invest. 1985;76(6):2403-2412. doi: https://doi.org/10.1172/JCI112253

93. Dhanwal DK, Sahoo S, Gautam VK, Saha R. Hip fracture patients in India have vitamin D deficiency and secondary hyperparathyroidism. Osteoporos Int. 2013;24(2):553-557. doi: https://doi.org/10.1007/s00198-012-1993-y

94. Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357-1364. doi: https://doi.org/10.3945/ajcn.111.031070.1

95. Binkley N, Gemar D, Engelke J, et al. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endocrinol Metab. 2011;96(4):981-988. doi: https://doi.org/10.1210/jc.2010-0015

96. Romagnoli E, Mascia ML, Cipriani C, et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab. 2008;93(8):3015-3020. doi: https://doi.org/10.1210/jc.2008-0350

97. Hassan AB, Hozayen RF, Alotaibi RA, Tayem YI. Therapeutic and maintenance regimens of vitamin D3 supplementation in healthy adults: A systematic review. Cell Mol Biol. 2018;64(14):8-14. doi: https://doi.org/10.14715/cmb/2018.64.14.2

98. Schleck ML, Souberbielle JC, Jandrain B, et al. A randomized, double-blind, parallel study to evaluate the dose-response of three different vitamin D treatment schemes on the 25-hydroxyvitamin D serum concentration in patients with vitamin D deficiency. Nutrients. 2015;7(7):5413-5422. doi: https://doi.org/10.3390/nu7075227

99. Fassio A, Adami G, Rossini M, et al. Pharmacokinetics of oral cholecalciferol in healthy subjects with vitamin D deficiency: A randomized open-label study. Nutrients. 2020;12(6):1-12. doi: https://doi.org/10.3390/nu12061553

100. De Niet S, Coffiner M, Da Silva S, et al. A randomized study to compare a monthly to a daily administration of vitamin D3 supplementation. Nutrients. 2018;10(6):1-9. doi: https://doi.org/10.3390/nu10060659

101. Rozhinskaya LY, Pigarova EA, Bagretsova AA, et al. High-doses of cholecalciferol for vitamin D deficiency treatment: results of an open-label, multicenter, comparative, randomized trial. Osteoporosis and Bone Diseases. 2021;23(3):4-16. (In Russ.). doi: https://doi.org/10.14341/osteo12697

102. AlAteeq MA, AlShail A, AlZahrani A, et al. Effect of Monthly and Bi-Monthly 50,000 International Units (IU) Maintenance Therapy With Vitamin D3 on Serum Level of 25-Hydroxyvitamin D in Adults: A Randomized Controlled Trial. Cureus. 2021;25(3). doi: https://doi.org/10.7759/cureus.13929

103. Pietras SM. Vitamin D2 Treatment for Vitamin D Deficiency and Insufficiency for Up to 6 Years. Arch Intern Med. 2009;169(19):1806. doi: https://doi.org/10.1001/archinternmed.2009.361

104. Sadat-Ali M, Al-Anii FM, Al-Turki HA, et al. Maintenance Dose of Vitamin D: How Much Is Enough? J Bone Metab. 2018;25(3):161. doi: https://doi.org/10.11005/jbm.2018.25.3.161

105. Heaney RP, Davies KM, Chen TC, et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77(1):204-210. doi: https://doi.org/10.1093/ajcn/77.1.204

106. Venugopal Y, Wan Muhamad SF, Musa N, et al. Maintenance vitamin D3 dosage requirements in Chinese women with post menopausal osteoporosis living in the tropics. Asia Pac J Clin Nutr. 2017;26(3):412-420. doi: https://doi.org/10.6133/apjcn.042016.10

107. de Oliveira LF, de Azevedo LG, da Mota Santana J, et al. Obesity and overweight decreases the effect of vitamin D supplementation in adults: systematic review and meta-analysis of randomized controlled trials. Rev Endocr Metab Disord. 2020;21(1):67-76. doi: https://doi.org/10.1007/s11154-019-09527-7

108. Drincic A, Fuller E, Heaney RP, Armas LAG. 25-Hydroxyvitamin D response to graded vitamin D3 supplementation among obese adults. J Clin Endocrinol Metab. 2013;98(12):4845-4851. doi: https://doi.org/10.1210/jc.2012-4103

109. Dhaliwal R, Mikhail M, Feuerman M, Aloia JF. The vitamin D dose response in obesity. Endocr Pract. 2014;20(12):1258-1264. doi: https://doi.org/10.4158/EP13518.OR

110. Sayadi Shahraki M, Khalili N, Yousefvand S, et al. Severe obesity and vitamin D deficiency treatment options before bariatric surgery: a randomized clinical trial. Surg Obes Relat Dis. 2019;15(9):1604-1611. doi: https://doi.org/10.1016/j.soard.2019.05.033

111. Mahlay NF, Verka LG, Thomsen K, et al. Vitamin D status before roux-en-Y and efficacy of prophylactic and therapeutic doses of vitamin D in patients after roux-en-Y gastric bypass surgery. Obes Surg. 2009;19(5):590-594. doi: https://doi.org/10.1007/s11695-008-9698-1

112. Krishnamoorthy G, Nair R, Sundar U, et al. Early predisposition to osteomalacia in Indian adults on phenytoin or valproate monotherapy and effective prophylaxis by simultaneous supplementation with calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: A prospective study. Neurol India. 2010;58(2):213-219. doi: https://doi.org/10.4103/0028-3886.63796

113. Zhou C, Assem M, Tay JC, et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest. 2006;116(6):1703-1712. doi: https://doi.org/10.1172/JCI27793

114. Carlin AM, Rao DS, Yager KM, et al. Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial. Surg Obes Relat Dis. 2009;5(4):444-449. doi: https://doi.org/10.1016/j.soard.2008.08.004

115. Goldner WS, Stoner JA, Lyden E, et al. Finding the optimal dose of vitamin d following roux-en-y gastric bypass: A prospective, randomized pilot clinical trial. Obes Surg. 2009;19(2):173-179. doi: https://doi.org/10.1007/s11695-008-9680-y

116. Collins N, Maher J, Cole M, et al. A prospective study to evaluate the dose of vitamin d required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. Qjm. 1991;78(2):113-122. doi: https://doi.org/10.1093/oxfordjournals.qjmed.a068530

117. Pilz S, Iodice S, Zittermann A, et al. Vitamin D status and mortality risk in CKD: A meta-analysis of prospective studies. Am J Kidney Dis. 2011;58(3):374-382. doi: https://doi.org/10.1053/j.ajkd.2011.03.020

118. Zhang Y, Darssan D, Pascoe EM, et al. Vitamin D status and mortality risk among patients on dialysis: A systematic review and meta-analysis of observational studies. Nephrol Dial Transplant. 2018;33(10):1742-1751. doi: https://doi.org/10.1093/ndt/gfy016

119. Jayedi A, Soltani S, Shab-Bidar S. Vitamin D status and all-cause mortality in patients with chronic kidney disease: A systematic review and dose-response meta-analysis. J Clin Endocrinol Metab. 2017;102(7):2136-2145. doi: https://doi.org/10.1210/jc.2017-00105

120. Alvarez JA, Wasse H, Tangpricha V. Vitamin D supplementation in pre-dialysis chronic kidney disease. Dermatoendocrinol. 2012;4(2):118-127. doi: https://doi.org/10.4161/derm.20014

121. Kandula P, Dobre M, Schold JD, et al. Vitamin D supplementation in chronic kidney disease: A systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol. 2011;6(1):50-62. doi: https://doi.org/10.2215/CJN.03940510

122. Xu C, Li YC, Zhao SM, Li ZX. Evaluation of responses to vitamin D3 (cholecalciferol) in patients on dialysis: A systematic review and meta-analysis. J Investig Med. 2016;64(5):1050-1059. doi: https://doi.org/10.1136/jim-2015-000032

123. Lu RJ, Zhu SM, Tang FL, et al. Effects of Vitamin D or its analogues on the mortality of patients with chronic kidney disease: An updated systematic review and meta-analysis. Eur J Clin Nutr. 2017;71(6):683-693. doi: https://doi.org/10.1038/ejcn.2017.59

124. Lishmanov A, Dorairajan S, Pak Y, et al. Treatment of 25-OH vitamin D deficiency in older men with chronic kidney disease stages 3 and 4 is associated with reduction in cardiovascular events. Am J Ther. 2013;20(5):480-486. doi: https://doi.org/10.1097/MJT.0b013e3182211b3b

125. Ketteler M, Block GA, Evenepoel P, et al. Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: Synopsis of the kidney disease: Improving global outcomes 2017 clinical practice guideline update. Ann Intern Med. 2018;168(6):422-430. doi: https://doi.org/10.7326/M17-2640

126. Feng R, Li Y, Li G, Li Z. Lower serum 25 (OH) D concentrations in type 1 diabetes : A meta-analysis. Diabetes Res Clin Pract. 2015;108(3):e71-e71. doi: https://doi.org/10.1016/j.diabres.2014.12.008

127. Shen L, Zhuang Q-S, Ji H-F. Assessment of vitamin D levels in type 1 and type 2 diabetes patients: Results from metaanalysis. Mol Nutr Food Res. 2016;60(5):1059-1067. doi: https://doi.org/10.1002/mnfr.201500937

128. Liu C, Lu M, Xia X, et al. Correlation of serum vitamin D level with type 1 diabetes mellitus in children : a meta-analysis. Nutr Hosp. 2015;32(4):1591-1594. doi: https://doi.org/10.3305/nh.2015.32.4.9198

129. Hou Y, Song A, Jin Y, Xia Q, Song G, Xing X. A dose–response meta-analysis between serum concentration of 25-hydroxy vitamin D and risk of type 1 diabetes mellitus. Eur J Clin Nutr. 2021;75(7):1010-1023. doi: https://doi.org/10.1038/s41430-020-00813-1

130. Guan SY, Cai HY, Wang P, et al. Association between circulating 25-hydroxyvitamin D and systemic lupus erythematosus: A systematic review and meta-analysis. Int J Rheum Dis. 2019;22(10):1803-1813. doi: https://doi.org/10.1111/1756-185X.13676

131. Bae S-C, Lee YH. Association between Vitamin D level and/or deficiency, and systemic lupus erythematosus: a meta-analysis. Cell Mol Biol (Noisy-le-grand). 2018;64(1):7-13. doi: https://doi.org/10.14715/cmb/2018.64.1.2

132. Islam MA, Khandker SS, Alam SS, et al. Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis. Autoimmun Rev. 2019;18(11):102392. doi: https://doi.org/10.1016/j.autrev.2019.102392

133. Wang J, Lv S, Chen G, et al. Meta-analysis of the association between vitamin D and autoimmune thyroid disease. Nutrients. 2015;7(4):2485-2498. doi: https://doi.org/10.3390/nu7042485

134. Taheriniya S, Arab A, Hadi A, et al. Vitamin D and thyroid disorders: a systematic review and Meta-analysis of observational studies. BMC Endocr Disord. 2021;21:171. doi: https://doi.org/10.1016/j.clnesp.2018.12.085

135. Xu MY, Cao B, Yin J, et al. Vitamin D and graves’ disease: A meta-analysis update. Nutrients. 2015;7(5):3813-3827. doi: https://doi.org/10.3390/nu7053813

136. Upala S, Sanguankeo A. Low 25-hydroxyvitamin D levels are associated with vitiligo: a systematic review and meta-analysis. Photodermatol Photoimmunol Photomed. 2016;32(4):181-190. doi: https://doi.org/10.1111/phpp.12241

137. Martínez-Lapiscina EH, Mahatanan R, Lee CH, et al. Associations of serum 25(OH) vitamin D levels with clinical and radiological outcomes in multiple sclerosis, a systematic review and meta-analysis. J Neurol Sci. 2020;411(5):116668. doi: https://doi.org/10.1016/j.jns.2020.116668

138. Ismailova K, Poudel P, Parlesak A, et al. Vitamin D in early life and later risk of multiple sclerosis — A systematic review, meta-analysis. PLoS One. 2019;14(8):1-18. doi: https://doi.org/10.1371/journal.pone.0221645

139. Lee YH, Bae S-C. Vitamin D level in rheumatoid arthritis and its correlation with the disease activity: a meta-analysis. Clin Exp Rheumatol. 2016;34:827-833.

140. Hiraki LT, Arkema EV, Cui J, et al. Circulating 25-hydroxyvitamin D level and risk of developing rheumatoid arthritis. Rheumatol (United Kingdom). 2014;53(12):2243-2248. doi: https://doi.org/10.1093/rheumatology/keu276

141. Lin J, Liu J, Davies ML, Chen W. Serum Vitamin D level and rheumatoid arthritis disease activity: Review and meta-analysis. PLoS One. 2016;11(1):1-17. doi: https://doi.org/10.1371/journal.pone.0146351

142. Li L, Chen J, Jiang Y. The association between vitamin D level and Sjögren’s syndrome: A meta-analysis. Int J Rheum Dis. 2019;22(3):532-533. doi: https://doi.org/10.1111/1756-185X.13474

143. Kuo CY, Huang YC, Lin KJ, Tsai TY. Vitamin d deficiency is associated with severity of dry eye symptoms and primary sjögren’s syndrome: A systematic review and meta-analysis. J Nutr Sci Vitaminol (Tokyo). 2020;66(4):386-388. doi: https://doi.org/10.3177/jnsv.66.386

144. Gregoriou E, Mamais I, Tzanetakou I, et al. The effects of vitamin D supplementation in newly diagnosed type 1 diabetes patients: Systematic review of randomized controlled trials. Rev Diabet Stud. 2017;14(2-3):260-268. doi: https://doi.org/10.1900/RDS.2017.14.260

145. McLaughlin L, Clarke L, Khalilidehkordi E, et al. Vitamin D for the treatment of multiple sclerosis: a meta-analysis. J Neurol. 2018;265(12):2893-2905. doi: https://doi.org/10.1007/s00415-018-9074-6

146. Berezowska M, Coe S, Dawes H. Effectiveness of vitamin D supplementation in the management of multiple sclerosis: A systematic review. Int J Mol Sci. 2019;20(6). doi: https://doi.org/10.3390/ijms20061301

147. Sousa JR, Rosa ÉPC, Nunes IF de OC, Carvalho CMRG de. Effect of vitamin D supplementation on patients with systemic lupus erythematosus: a systematic review. Rev Bras Reumatol (English Ed. 2017;57(5):466-471. doi: https://doi.org/10.1016/j.rbre.2017.08.001

148. Wang S, Wu Y, Zuo Z, et al. The effect of vitamin D supplementation on thyroid autoantibody levels in the treatment of autoimmune thyroiditis: a systematic review and a meta-analysis. Endocrine. 2018;59(3):499-505. doi: https://doi.org/10.1007/s12020-018-1532-5

149. Jagannath VA, Filippini G, Di Pietrantonj C, et al. Vitamin D for the management of multiple sclerosis. Cochrane Database Syst Rev. 2018;2018(9). doi: https://doi.org/10.1002/14651858.CD008422.pub3

150. Yuan X, Guo L, Jiang C, et al. The Effect of Different Administration Time and Dosage of Vitamin D Supplementation in Patients with Multiple Sclerosis: A Meta-Analysis of Randomized Controlled Trials. Neuroimmunomodulation. 2021;28(3):118-128. doi: https://doi.org/10.1159/000515131

151. Zheng R, Gonzalez A, Yue J, et al. Efficacy and Safety of Vitamin D Supplementation in Patients With Systemic Lupus Erythematosus: A Meta-analysis of Randomized Controlled Trials. Am J Med Sci. 2019;358(2):104-114. doi: https://doi.org/10.1016/j.amjms.2019.04.020

152. Cianferotti L, Bertoldo F, Bischoff-Ferrari HA, et al. Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis. Endocrine. 2017;56:245-261. doi: https://doi.org/10.1007/s12020-017-1290-9

153. Autier P, Mullie P, Macacu A, et al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol. 2017;5(12):986-1004. doi: https://doi.org/10.1016/S2213-8587(17)30357-1

154. Hahn J, Cook N, Alexander E, et al. Vitamin D and Marine n-3 Fatty Acid Supplementation and Prevention of Autoimmune Disease in the VITAL Randomized Controlled Trial [abstract]. Arthritis Rheumatol. 2021;73(S.10)

155. Hollis BW, Johnson D, Hulsey TC, et al. Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res. 2011;26(10):2341-2357. doi: https://doi.org/10.1002/jbmr.463

156. Yu CKH, Sykes L, Sethi M, et al. Vitamin D deficiency and supplementation during pregnancy. Clin Endocrinol (Oxf). 2009;70(5):685-690. doi: https://doi.org/10.1111/j.1365-2265.2008.03403.x

157. Karamali M, Beihaghi E, Mohammadi AA, Asemi Z. Effects of high-dose Vitamin D supplementation on metabolic status and pregnancy outcomes in pregnant women at risk for pre-eclampsia. Horm Metab Res. 2015;47(12):867-872. doi: https://doi.org/10.1055/s-0035-1548835

158. Rostami M, Tehrani FR, Simbar M, et al. Effectiveness of prenatal Vitamin D deficiency screening and treatment program: A stratified randomized field trial. J Clin Endocrinol Metab. 2018;103(8):2936-2948. doi: https://doi.org/10.1210/jc.2018-00109

159. Yap C, Cheung NW, Gunton JE, et al. Vitamin D supplementation and the effects on glucose metabolism during pregnancy: A randomized controlled trial. Diabetes Care. 2014;37(7):1837-1844. doi: https://doi.org/10.2337/dc14-0155

160. Palacios C, Trak-Fellermeier MA, Martinez RX, et al. Regimens of vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019;2019(10). doi: https://doi.org/10.1002/14651858.CD013446

161. Amiri Z, Nosrati M, Sharifan P, et al. Factors determining the serum 25-hydroxyvitamin D response to vitamin D supplementation: Data mining approach.. BioFactors. 2021;47(5):828-836. doi: https://doi.org/10.1002/biof.1770

162. Tepper S, Shahar DR, Geva D, Ish-Shalom S. Predictors of serum 25(Oh)D increase following bimonthly supplementation with 100,000 IU vitamin D in healthy, men aged 25-65 years. J Steroid Biochem Mol Biol. 2014;144(PART A):163-166. doi: https://doi.org/10.1016/j.jsbmb.2013.12.005

163. Davies M, Mawer EB, Klass HJ, et al. Vitamin D deficiency, osteomalacia, and primary biliary cirrhosis — Response to orally administered vitamin D3. Dig Dis Sci. 1983;28(2):145-153. doi: https://doi.org/10.1007/BF01315144

164. Carmel AS, Shieh A, Bang H, Bockman RS. The 25(OH)D level needed to maintain a favorable bisphosphonate response is ≥33 ng/ml. Osteoporos Int. 2012;23(10):2479-2487. doi: https://doi.org/10.1007/s00198-011-1868-7

165. Peris P, Martínez-Ferrer A, Monegal A, et al. 25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis. Bone. 2012;51(1):54-58. doi: https://doi.org/10.1016/j.bone.2012.03.026

166. Heaney RP, Weaver CM. Oxalate: effect on calcium absorbability. Am J Clin Nutr. 1989;50(4):830-832. doi: https://doi.org/10.1093/ajcn/50.4.830

167. Borghi L, Schianchi T, Meschi T, et al. Comparison of Two Diets for the Prevention of Recurrent Stones in Idiopathic Hypercalciuria. N Engl J Med. 2002;346(2):77-84. doi: https://doi.org/10.1056/NEJMoa010369

168. Nuzzo V, de Milita AM, Ferraro T, et al. Analysis of Skeletal Status by Quantitative Ultrasonometry in a Cohort of Postmenopausal Women with High Blood Cholesterol Without Documented Osteoporosis. Ultrasound Med Biol. 2009;35(5):717-722. doi: https://doi.org/10.1016/j.ultrasmedbio.2008.11.003

169. Corgneau M, Scher J, Ritie-Pertusa L, et al. Recent advances on lactose intolerance: Tolerance thresholds and currently available answers. Crit Rev Food Sci Nutr. 2017;57(15):3344-3356. doi: https://doi.org/10.1080/10408398.2015.1123671

170. Dupont C, Chouraqui JP, Linglart A, et al. Nutritional management of cow’s milk allergy in children: An update. Arch Pediatr. 2018;25(3):236-243. doi: https://doi.org/10.1016/j.arcped.2018.01.007

171. Calcium calculator [Internet]. Available from: https://www.osteoporosis.foundation/educational-hub/topic/calcium/list-of-calcium-content-of-common-foods [cited: 28.07.2021].

172. Naghshi S, Naemi M, Sadeghi O, et al. Total, dietary, and supplemental calcium intake and risk of all-cause cardiovascular, and cancer mortality: a systematic review and dose-response meta-analysis of prospective cohort studies. Crit Rev Food Sci Nutr. 2021;346(2):1-12. doi: https://doi.org/10.1080/10408398.2021.1890690

173. Asemi Z, Saneei P, Sabihi SS, et al. Total, dietary, and supplemental calcium intake and mortality from all-causes, cardiovascular disease, and cancer: A meta-analysis of observational studies. Nutr Metab Cardiovasc Dis. 2015;25(7):623-634. doi: https://doi.org/10.1016/j.numecd.2015.03.008

174. Wood RJ, Serfaty-Lacrosniere C. Gastric Acidity, Atrophic Gastritis, and Calcium Absorption. Nutr Rev. 2009;50(2):33-40. doi: https://doi.org/10.1111/j.1753-4887.1992.tb02510.x

175. Ziemińska M, Sieklucka B, Pawlak K. Vitamin k and d supplementation and bone health in chronic kidney disease—apart or together? Nutrients. 2021;13(3):1-34. doi: https://doi.org/10.3390/nu13030809

176. Kuang X, Liu C, Guo X, et al. The combination effect of vitamin K and vitamin D on human bone quality: A meta-analysis of randomized controlled trials. Food Funct. 2020;11(4):3280-3297. doi: https://doi.org/10.1039/c9fo03063h

177. Taylor PN, Davies JS. A review of the growing risk of vitamin D toxicity from inappropriate practice. Br J Clin Pharmacol. 2018;84(6):1121-1127. doi: https://doi.org/10.1111/bcp.13573

178. Spiller HA, Good TF, Spiller NE, Aleguas A. Vitamin D exposures reported to US poison centers 2000-2014. Hum Exp Toxicol. 2016;35(5):457-461. doi: https://doi.org/10.1177/0960327115595685

179. Tebben PJ, Singh RJ, Kumar R. Vitamin D-mediated hypercalcemia: Mechanisms, diagnosis, and treatment. Endocr Rev. 2016;37(5):521-547. doi: https://doi.org/10.1210/er.2016-1070

180. Rooney M, Harnack L, Michos E, et al. Trends in Use of High Dose Vitamin D Supplements Exceeding 1,000 or 4,000 International Units Daily, 1999-2014. JAMA. 2017;317(23):2448-2450. doi: https://doi.org/10.1001/jama.2017.4392.Trends

181. Gallagher JC, Smith LM, Yalamanchili V. Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women. Menopause. 2014;21(11):1173-1180. doi: https://doi.org/10.1097/gme.0000000000000270

182. Jones G, Prosser DE, Kaufmann M. Cytochrome P450-mediated metabolism of vitamin D. 2014;55:13-31. doi: https://doi.org/10.1194/jlr.R031534

183. O’Donnell S, Moher D, Thomas K, et al. Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls. J Bone Miner Metab. 2008;26(6):531-542. doi: https://doi.org/10.1007/s00774-008-0868-y

184. Richy F, Dukas L, Schacht E. Differential effects of D-hormone analogs and native vitamin D on the risk of falls: A comparative meta-analysis. Calcif Tissue Int. 2008;82(2):102-107. doi: https://doi.org/10.1007/s00223-008-9102-0

185. Demetriou ETW, Travison TG, Holick MF. Treatment with 50 000 IU vitamin D2 every other week and effect on serum 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, and total 25-hydroxyvitamin D in a clinical setting. Endocr Pract. 2012;18(3):399-402. doi: https://doi.org/10.4158/EP11268.OR

186. Logan VF, Gray AR, Peddie MC, et al. Long-term vitamin D3 supplementation is more effective than vitamin D2 in maintaining serum 25-hydroxyvitamin D status over the winter months. Br J Nutr. 2013;109(6):1082-1088. doi: https://doi.org/10.1017/S0007114512002851

187. Oliveri B, Mastaglia SR, Brito GM, et al. Vitamin D3 seems more appropriate than D2 to sustain adequate levels of 25OHD: A pharmacokinetic approach. Eur J Clin Nutr. 2015;69(6):697-702. doi: https://doi.org/10.1038/ejcn.2015.16

188. German Nutrition Society. New reference values for Vitamin D. Ann Nutr Metab. 2012;60(4):241-246. doi: https://doi.org/10.1159/000337547

189. Pludowski P, Karzczmarewicz E, Bayer M, Al E. Practical Guidelines for the Supplementation of Vitamin D and the Treatment of Deficits in Central Europe. Endokrynol Pol. 2013;64(4):319-327. doi: https://doi.org/10.5603/EP

190. Cashman K, Ritz C, Kiely M. Improved Dietary Guidelines for Vitamin D: Application of Individual Participant Data (IPD)-Level Meta-Regression Analyses. Nutrients. 2017;9(5):469. doi: https://doi.org/10.3390/nu9050469

191. Zhao JG, Zeng XT, Wang J, Liu L. Association between calcium or Vitamin D supplementation and fracture incidence in community-dwelling older adults a systematic review and meta-analysis. JAMA. 2017;318(24):2466-2482. doi: https://doi.org/10.1001/jama.2017.19344

192. Weaver CM, Alexander DD, Boushey CJ, et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int. 2016;27(1):367-376. doi: https://doi.org/10.1007/s00198-015-3386-5

193. Bolland MJ, Grey A, Avenell A. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018;6(11):847-858. doi: https://doi.org/10.1016/S2213-8587(18)30265-1

194. Grossman DC, Curry SJ, Owens DK, et al. Vitamin D, calcium, OR combined supplementation for the primary prevention of fractures in community-dwelling adults us Preventive Services Task Force recommendation statement. JAMA. 2018;319(15):1592-1599. doi: https://doi.org/10.1001/jama.2018.3185

195. Bischoff-Ferrari HA, Orav EJ, Abderhalden L, et al. Vitamin D supplementation and musculoskeletal health. Lancet Diabetes Endocrinol. 2019;7(2):85. doi: https://doi.org/10.1016/S2213-8587(18)30347-4

196. Macdonald HM, Reid IR, Gamble GD, et al. 25-Hydroxyvitamin D Threshold for the Effects of Vitamin D Supplements on Bone Density: Secondary Analysis of a Randomized Controlled Trial. J Bone Miner Res. 2018;33(8):1464-1469. doi: https://doi.org/10.1002/jbmr.3442

197. Reid IR, Horne AM, Mihov B, et al. Effect of monthly high-dose vitamin D on bone density in community-dwelling older adults substudy of a randomized controlled trial. J Intern Med. 2017;282(5):452-460. doi: https://doi.org/10.1111/joim.12651

198. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: A randomized controlled trial. JAMA. 2010;303(18):1815-1822. doi: https://doi.org/10.1001/jama.2010.594

199. Smith H, Anderson F, Raphael H, et al. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women — A population-based, randomized, double-blind, placebo-controlled trial. Rheumatology. 2007;46(12):1852-1857. doi: https://doi.org/10.1093/rheumatology/kem240

200. Kahwati LC, Leblanc E, Weber RP, et al. Screening for Vitamin D Deficiency in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021;325(14):1443-1463. doi: https://doi.org/10.1001/jama.2020.26498

201. Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol. 2014;144(PART A):138-145. doi: https://doi.org/10.1016/j.jsbmb.2013.11.003

202. Cristina P, Lia K K, Juan Pablo P-R. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019;7(7):CD008873. doi: https://doi.org/10.1016/j.explore.2019.10.002

203. Yu CKH, Sykes L, Sethi M, et al. Vitamin D deficiency and supplementation during pregnancy. Obstet Gynecol. 2011;118(1):197-198. doi: https://doi.org/10.1111/j.1365-2265.2008.03403.x

204. Grant CC, Stewart AW, Scragg R, et al. Vitamin D During Pregnancy and Infancy and Infant Serum 25-Hydroxyvitamin D Concentration. Pediatrics. 2014;133(1):e143-e153. doi: https://doi.org/10.1542/peds.2013-2602

205. Galior K, Grebe S, Singh R. Development of Vitamin D Toxicity from Overcorrection of Vitamin D Deficiency: A Review of Case Reports. Nutrients. 2018;10(8):953. doi: https://doi.org/10.3390/nu10080953

206. Dashant K, John DB, Dhanwada R, et al. Elevated 1,25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis. Respir Med. 2010;104(4):564-570. doi: https://doi.org/10.1016/j.rmed.2009.12.004

207. Bolanowski M, Bednarczuk T, Bobek-Billewicz B, et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe — recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013;64(6):480-493. doi: https://doi.org/10.5603/EP

208. Billington EO, Burt LA, Rose MS, et al. Safety of High-Dose Vitamin D Supplementation: Secondary Analysis of a Randomized Controlled Trial. J Clin Endocrinol Metab. 2020;105(4):1261-1273. doi: https://doi.org/10.1210/clinem/dgz212